Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for reducing transfusion need in children receiving chemotherapy
IRCT2015061822805N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of erythropoietin in chemotherapy-induced anaemia (CIA) and Nonhematologic neoplasms, sponsored by Tabriz University of Medical Sciences. Started Apr 2014; status: completed.
02
Drugs
erythropoietin
03
Conditions
chemotherapy-induced anaemia (CIA)Nonhematologic neoplasms
Beyond the preview
Go deeper on IRCT2015061822805N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015061822805N1.